Search results :

Deferiprone

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: V03AC02

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2
Anaphylactic shock postmarketing x
Atrial fibrillation postmarketing x
Mental disorder postmarketing x
Bruxism postmarketing x
Chondropathy postmarketing x
Cerebellar syndrome postmarketing x
Infection postmarketing x
Connective tissue disorder postmarketing x x
Dehydration postmarketing x
Diplopia postmarketing x x
Encephalitis postmarketing x
Enterocolitis postmarketing x
Epistaxis postmarketing x
Rash postmarketing x x
Eye disorder postmarketing x
Body temperature increased postmarketing x
Gastrointestinal disorder postmarketing x x
Glycosuria postmarketing x
Cardiac disorder postmarketing x
Cardiac failure postmarketing x
Haemoglobinuria postmarketing x
Haemoptysis postmarketing x
Hepatitis postmarketing x
Hepatomegaly postmarketing x
Hyperhidrosis postmarketing x
Hypersensitivity postmarketing x x
Hypertension postmarketing x
Hypotension postmarketing x
Immune system disorder postmarketing x x
Jaundice postmarketing x
Nephropathy postmarketing x
Mediastinal disorder postmarketing x
Multi-organ failure postmarketing x
Myositis postmarketing x
Nervous system disorder postmarketing x x
Obsessive-compulsive disorder postmarketing x
Pancreatitis postmarketing x
Pancytopenia postmarketing x
Papilloedema postmarketing x
Pharyngitis postmarketing x
Pneumonia postmarketing x
Pruritus postmarketing x
Pulmonary embolism postmarketing x
Henoch-Schonlein purpura postmarketing x
Acute respiratory distress syndrome postmarketing x
Convulsion postmarketing x
Gastric ulcer postmarketing x
Trismus postmarketing x
Urticaria postmarketing x x
Angiopathy postmarketing x
Chills postmarketing x
Rash pustular postmarketing x
Oedema peripheral postmarketing x
Periorbital oedema postmarketing x
Intracranial pressure increased postmarketing x
Malnutrition postmarketing x x
Photosensitivity reaction postmarketing x
Metabolic acidosis postmarketing x
Subcutaneous abscess postmarketing x
Furuncle postmarketing x
Sepsis postmarketing x
Rectal haemorrhage postmarketing x
Hepatobiliary disease postmarketing x
Blood bilirubin increased postmarketing x
Parotid gland enlargement postmarketing x
Gait disturbance postmarketing x
Thrombocytosis postmarketing x
Infestation NOS postmarketing x
Blood and lymphatic system disorders postmarketing x x
Retinal toxicity postmarketing x
Psychomotor skills impaired postmarketing x
Cryptococcal cutaneous infection postmarketing x
Pyramidal tract syndrome postmarketing x
Somnolence postmarketing x
Cerebral haemorrhage postmarketing x
Abdominal pain x x
Agranulocytosis x x
Arthralgia x x
Arthritis x
Back pain x
Diarrhoea x x
Dyspepsia x
Effusion x
Fatigue x
Fibrosis x
Headache x x
Hepatitis C x
Hypersplenism x
Arthropathy x x
Hypotonia x
Nausea x x
Neutropenia x x
Nystagmus x
Pain x
Pain in extremity x
Torsade de pointes x
Urinary tract disorder x
Vomiting x x
Weight increased x
Aspartate aminotransferase increased x
Alanine aminotransferase increased x
Unspecified disorder of skin and subcutaneous tissue x
Disability x
Increased appetite x x
Decreased appetite x
Discomfort x
Gastrointestinal symptom NOS x
Urine color abnormal x
Chromaturia x x
Neutrophil count decreased x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

deferiprone / deferiprone

Side effects:33
Source:EMA

DEFERIPRONE

Side effects:98
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label